Related Experiment Video
Updated: May 22, 2026
04:13
Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
Nighttime activity in individuals with dementia: understanding the problem and identifying solutions
Catherine A Greenblum1, Meredeth A Rowe
1University of South Florida College of Nursing, Tampa, FL, USA. cgreenbl@health.usf.edu
Journal of Gerontological Nursing
|April 27, 2012
Summary
Over half of dementia patients experience sleep disturbances, leading to risks like falls and wandering. This review examines causes and interventions for nighttime activity in home-dwelling individuals with dementia.
Area of Science:
- Gerontology
- Neurology
- Sleep Medicine
Background:
- Sleep disturbances affect over 50% of individuals with dementia.
- Nighttime activity in dementia patients poses risks such as falls and home exits.
- These issues create significant challenges for both patients and caregivers.
Purpose of the Study:
- To review current research on the causes of sleep disturbances in dementia patients.
- To explore interventions for managing nighttime activity in home-dwelling individuals with dementia.
Main Methods:
- Literature review of existing research.
- Analysis of studies focusing on sleep disturbances and nighttime behaviors in dementia.
- Synthesis of findings on causes and interventions.
Main Results:
- Identified common causes of sleep disturbances in dementia.
- Summarized risks associated with nighttime awakenings, including falls and wandering.
- Highlighted various intervention strategies for managing nighttime activity.
Conclusions:
- Sleep disturbances are prevalent in dementia, necessitating targeted interventions.
- Effective management strategies can mitigate risks and improve quality of life for dementia patients and caregivers.
- Further research is needed to refine and validate interventions for nighttime activity.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:17Sleepwalking and Sleep Talking
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...